Official ESCRS | European Society of Cataract & Refractive Surgeons
Vienna 2018 Delegate Registration Programme Exhibition Virtual Exhibition Satellites 2018 Survey


escrs app advert


Search Title by author or title

Corneal decompensation post implantation of an iris-claw phakic intraocular lens (Artisan) associated with interface fluid syndrome treated by Descemet's membrane endothelial keratoplasty (DMEK)

Poster Details

First Author: N.Jurado ECUADOR

Co Author(s):    M. Naveiras   J. Alfonso                 

Abstract Details


To describe a case of corneal decompensation post implantation of an iris –claw phakic intraocular lens (ARTISAN) associated with Interface Fluid Syndrome treated by Descemet Membrane Endothelial Keratoplasty.


Instituto Universitario Fernandez-Vega, Oviedo, Spain


A 55 years old female underwent a bilateral implantation of an iris–claw phakic intraocular lens followed by Laser in situ Keratomileusis (LASIK) for the correction of residual myopic defect. Thirteen years later a fixation loss of the haptics produced corneal decompensation with ocular hypertension and Interface Fluid Syndrome associated in her left eye. The iris –claw intraocular phakic lens was removed and a refractive lensectomy with intraocular lens implantation was performed. The visual impairment secondary to the corneal and macula edema was important therefore the reapplication of the LASIK flap and DMEK was carried out in her left eye.


After the reapplication technique used there was no interface fluid between the stroma and the LASIK flap. Complete graft apposition was achieved with corneal transparency recovery. By 8 months postoperatively the patient’s best spectacle corrected vision had improved from 20/200 to 20/30 where it remained stable.


A careful treatment of the LASIK flap during the DMEK procedure is necessary for a correct resolution of both problems. Decompensation of the cornea after a cataract surgery in patients who have had LASIK could make the Interface Fluid Syndrome a common pathology in our practice. We found that this approach is a complete, safe and effective surgical management for this pathology.

Financial Disclosure:


Back to Poster listing